epigallocatechin gallate has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, PP; Chu, WK; Du, L; He, JN; Ho, BM; Ng, DS; Pang, CP; Tham, CC; Zhou, L | 1 |
| Balestrazzi, E; Colotto, A; Di Landro, S; Falsini, B; Guccione, L; Marangoni, D; Montrone, L; Salgarello, T; Stifano, G | 1 |
1 trial(s) available for epigallocatechin gallate and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram.
Topics: Adult; Aged; Antioxidants; Catechin; Cross-Over Studies; Double-Blind Method; Electroretinography; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Pattern Recognition, Visual; Retinal Ganglion Cells; Visual Field Tests; Visual Fields | 2009 |
1 other study(ies) available for epigallocatechin gallate and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress.
Topics: Animals; Endoplasmic Reticulum Stress; Glaucoma, Open-Angle; Humans; Swine; Trabecular Meshwork; Tunicamycin | 2022 |